Dymon Asia Capital (Singapore) Pte. Ltd. Moderna, Inc. Transaction History

Dymon Asia Capital (Singapore) Pte. Ltd.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$117.13 - $176.59 $718,943 - $1.08 Million	6,138 Added 102.42%	12,131 $1.73 Million
Q1 2022 May 13, 2022	SELL	$126.46 - $235.05 $466,131 - $866,394	-3,686 Reduced 38.08%	5,993 $1.03 Million
Q1 2021 May 14, 2021	BUY	$109.18 - $185.98 $1.06 Million - $1.8 Million	9,679 New	9,679 $1.27 Million

954

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $14.4B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Dymon Asia Capital (Singapore) Pte. Ltd., based on Form 13F filings with the SEC.

Stay updated on Dymon Asia Capital (Singapore) Pte. Ltd. with notifications on news.